Cordyceps Sunshine Biotech Holdings (RAJAF) Liabilities from Discontinued Operations (2022 - 2023)

Cordyceps Sunshine Biotech Holdings (RAJAF) recorded quarterly Liabilities from Discontinued Operations of 949455.0 in Q3 2023, down 12.55% quarter-over-quarter from 1085744.0 in Q4 2022.

Cordyceps Sunshine Biotech Holdings (RAJAF) Liabilities from Discontinued Operations (2022 - 2023) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 949455.0 for Q3 2023.

  • In Q3 2023, Liabilities from Discontinued Operations changed N/A year-over-year to 949455.0; the TTM figure through Sep 2023 stood at 949455.0 (changed N/A YoY), while the FY2022 annual figure was 1085744.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations was 949455.0 for Q3 2023 at Cordyceps Sunshine Biotech Holdings, down from 1085744.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 1085744.0 in Q4 2022 to a low of 949455.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Paranovus Entertainment Technology 12,507.92 Bn 12,507.92 Bn -
2 Kraft Heinz 27.05 Bn 22.98 Bn 2.22 Bn
3 General Mills 17.93 Bn 17.16 Bn 1.37 Bn
4 Jbs 13.56 Bn 8.99 Bn 2.32 Bn
5 Hormel Foods 13.29 Bn 12.44 Bn 518.51 Mn
6 Mccormick 12.45 Bn 12.85 Bn 708.90 Mn
7 Magnum Ice Cream 11.94 Bn 11.47 Bn -
8 J M Smucker 11.83 Bn 11.77 Bn 862.10 Mn
9 Smithfield Foods 9.80 Bn 8.73 Bn 511.00 Mn
10 Cordyceps Sunshine Biotech Holdings - - -

Historic Data

Download Data
DateValue
Sep 30, 2023 949,455.00
Sep 30, 2023 949,455.00
Dec 31, 2022 1.09 Mn
Dec 31, 2022 1.09 Mn